Home insulin pump use feasible for hospitalised children with type 1 diabetes
![Diabetic child applying an insulin pump dressing in his abdomen with the doctor in the clinic](https://www.medwirenews.com/wp-content/uploads/2024/03/AdobeStock_223435832_insulin-pump_child.jpeg)
For children with type 1 diabetes who are admitted to hospital, continuing with a home insulin pump is feasible for the prevention of hyperglycemia and hypoglycemia, suggests research published in JAMA Network Open.
Rationale for antiviral therapy in new-onset type 1 diabetes
![](https://www.medwirenews.com/wp-content/uploads/2023/11/iStock-865805190-mwn.jpg)
Antiviral therapy may preserve residual insulin production in children and adolescents newly diagnosed with type 1 diabetes, suggest findings from the DiViD intervention study.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Mild gestational glucose intolerance tied to future type 2 diabetes risk
![](https://www.medwirenews.com/wp-content/uploads/2023/04/AdobeStock_483658175-1MWN.jpg)
Impaired glucose tolerance during pregnancy that does not meet the criteria for gestational diabetes nevertheless increases the likelihood that women will later develop type 2 diabetes, a study shows.
Health informatics system aids timely, equitable diabetes care
![](https://www.medwirenews.com/wp-content/uploads/2023/03/AdobeStock_539212784-MWN.png)
A health informatics system based on routine clinical data helps physicians to prioritize high-risk people with diabetes, deliver more equitable care, and manage healthcare capacity, report researchers.
Obesity as prevalent in type 1 diabetes as general US population
![](https://www.medwirenews.com/wp-content/uploads/2023/02/Fotolia_21084973_Subscription_Yearly_XL-MWNWP.jpg)
There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.
TriMaster data support ‘try before you choose’ for type 2 diabetes medications
![](https://www.medwirenews.com/wp-content/uploads/2022/12/AdobeStock_298416620-mwn.jpg)
Allowing people to trial medications for type 2 diabetes and choose their preferred one is a viable approach in the absence of a clear clinical indication.
Meta-analysis backs SGLT2 inhibitors for kidney disease
![](https://www.medwirenews.com/wp-content/uploads/2022/11/AdobeStock_123630438-MWN.jpg)
A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.
Real-world adjunctive medication outcomes in type 1 diabetes revealed
![Tablets and syringe](https://www.medwirenews.com/wp-content/uploads/2022/06/AdobeStock_72928505resize.jpg)
People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.
Diabetes ‘no longer a CVD risk equivalent’
![](https://www.medwirenews.com/wp-content/uploads/2022/10/iStock-1339093358-mwn.jpg)
The strength of the association between diabetes and the risk for cardiovascular events has lessened over recent years, report researchers.
Cost drives one in six US adults to ration insulin
![](https://www.medwirenews.com/wp-content/uploads/2022/10/iStock-1303306034-1.jpg)
Findings from a nationally representative US survey show that a substantial minority of people with diabetes ration their use of insulin because of issues with affordability.